Found: 28
Select item for more details and to access through your institution.
Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. Edited by Edna B. Foa, Terence M. Keane and Matthew J. Friedman. The Guilford Press, New York, NY, 2000. 379pp, ISBN: 157230 5843.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
Global meaning and psychological adjustment among survivors of bone marrow transplant.
- Published in:
- Psycho-Oncology, 2001, v. 10, n. 1, p. 29, doi. 10.1002/1099-1611(200101/02)10:1<29::AID-PON482>3.0.CO;2-Y
- By:
- Publication type:
- Article
CONNECTING THE DISCONNECTED: ADULT DAY CARE FOR PEOPLE WITH AIDS IN NEW YORK CITY.
- Published in:
- Health & Social Work, 1992, v. 17, n. 4, p. 273, doi. 10.1093/hsw/17.4.273
- By:
- Publication type:
- Article
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
- Published in:
- Frontiers in Psychology, 2023, p. 01, doi. 10.3389/fpsyg.2023.1062830
- By:
- Publication type:
- Article
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments.
- Published in:
- Diabetes Care, 2023, v. 46, n. 8, p. 1448, doi. 10.2337/dc22-2037
- By:
- Publication type:
- Article
Risk Management for the 21st Century: Current Status and Future Needs.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 409, doi. 10.1007/s40264-020-01033-z
- By:
- Publication type:
- Article
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Trauma Symptoms in Bone Marrow Transplant Survivors: The Role of Nonmedical Life Events.
- Published in:
- Journal of Traumatic Stress, 2001, v. 14, n. 1, p. 95, doi. 10.1023/A:1007839732523
- By:
- Publication type:
- Article
Validation of the PTSD Checklist–Civilian Version in Survivors of Bone Marrow Transplantation.
- Published in:
- Journal of Traumatic Stress, 1999, v. 12, n. 3, p. 485, doi. 10.1023/A:1024719104351
- By:
- Publication type:
- Article
Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.710518
- By:
- Publication type:
- Article
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.602112
- By:
- Publication type:
- Article
The use of implementation science theories, models, and frameworks in implementation research for medicinal products: A scoping review.
- Published in:
- Health Research Policy & Systems, 2024, v. 22, p. 1, doi. 10.1186/s12961-024-01102-0
- By:
- Publication type:
- Article
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 2509, doi. 10.2147/PPA.S327006
- By:
- Publication type:
- Article
Detecting signals of opioid analgesic abuse: application of a spatial mixed effect poisson regression model using data from a network of poison control centers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 11, p. 1050, doi. 10.1002/pds.1658
- By:
- Publication type:
- Article
Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework.
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 3, p. 1, doi. 10.2196/16430
- By:
- Publication type:
- Article
The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 12, p. 1532, doi. 10.1002/pds.5167
- By:
- Publication type:
- Article
What is the quality of drug safety information for patients: An analysis of REMS educational materials.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 9, p. 969, doi. 10.1002/pds.4614
- By:
- Publication type:
- Article
New Opportunities for Integrating Drug Safety Risk Management Programs Into the Health Care System: Bridging the Divide.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Housing status and health care service utilization among low-income persons with HIV/AIDS.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE).
- Published in:
- Drug Safety, 2024, v. 47, n. 7, p. 655, doi. 10.1007/s40264-024-01417-5
- By:
- Publication type:
- Article
Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom.
- Published in:
- Drug Safety, 2022, v. 45, n. 3, p. 259, doi. 10.1007/s40264-022-01165-4
- By:
- Publication type:
- Article
Patients as research partners in preference studies: learnings from IMI-PREFER.
- Published in:
- Research Involvement & Engagement, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40900-023-00430-9
- By:
- Publication type:
- Article
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved.
- Published in:
- Therapeutics & Clinical Risk Management, 2015, v. 11, p. 339, doi. 10.2147/TCRM.S78202
- By:
- Publication type:
- Article